1- (4- di- hydroxy- 3,5- dioxa- 4- borabicyclo(4.4.0)deca- 7,9,11- trien- 9- yl)- 2- (tert- butylamino)ethanol
Adrenergic beta-Agonist; structure in first source
Also Known As:
BR-AEA cpd
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results